ID: ALA498415

Max Phase: Preclinical

Molecular Formula: C9H10N2O4

Molecular Weight: 210.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1c(O)cccc1C(=O)NCC(=O)O

Standard InChI:  InChI=1S/C9H10N2O4/c10-8-5(2-1-3-6(8)12)9(15)11-4-7(13)14/h1-3,12H,4,10H2,(H,11,15)(H,13,14)

Standard InChI Key:  MGBDUMHMFHGGKI-UHFFFAOYSA-N

Associated Targets(Human)

Kynureninase 42 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 210.19Molecular Weight (Monoisotopic): 210.0641AlogP: -0.21#Rotatable Bonds: 3
Polar Surface Area: 112.65Molecular Species: ACIDHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.47CX Basic pKa: 3.84CX LogP: -0.53CX LogD: -3.36
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.41Np Likeness Score: -0.12

References

1. Lima S, Kumar S, Gawandi V, Momany C, Phillips RS..  (2009)  Crystal structure of the Homo sapiens kynureninase-3-hydroxyhippuric acid inhibitor complex: insights into the molecular basis of kynureninase substrate specificity.,  52  (2): [PMID:19143568] [10.1021/jm8010806]

Source